Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
RMA was founded in 1999 by Drs.
Jun 2003 Opening of the new headquarters building, donated by the Government of Korea and initiation of IVI’s Laboratory Sciences.
Jun 2003 BMGF awards a grant to launch the Pediatric Dengue Vaccine Initiative (PDVI) to accelerate the development and introduction of new dengue vaccines in dengue-endemic countries.
Oct 2007 BMGF awards a grant to launch the Vi-based Vaccines for Asia (VIVA) Initiative to develop and introduce new and improved Vi-based typhoid vaccines.
Apr 2010 Launch of the Typhoid Fever Surveillance in sub-Saharan Africa Program (TSAP), supported by BMGF, to assess the burden of typhoid in 10 countries in Africa.
May 2015 IVI’s International Advanced Vaccinology Course in the Asia-Pacific Region celebrates its 15th year.
Feb 2015 The Korean Ministry of Food & Drug Safety grants an export license to EuBiologics’ oral cholera vaccine, Euvichol.
Before joining Tuxera in 2016, Tiff wrote about technology, consumer electronics, and industrial tech for Nokia, Microsoft, KONE Corporation, and many others.
Rate IVI International, Inc.'s efforts to communicate its history to employees.
Do you work at IVI International, Inc.?
Is IVI International, Inc.'s vision a big part of strategic planning?
Zippia gives an in-depth look into the details of IVI International, Inc., including salaries, political affiliations, employee data, and more, in order to inform job seekers about IVI International, Inc.. The employee data is based on information from people who have self-reported their past or current employments at IVI International, Inc.. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by IVI International, Inc.. The data presented on this page does not represent the view of IVI International, Inc. and its employees or that of Zippia.
IVI International, Inc. may also be known as or be related to IVI International, Inc. and Inspection & Valuation International Inc.